This article originally contained the following statement in reference to ZELNORM (tegaserod): "It is not prescribed in the USA." However, on August 15, 2019, ZELNORM (tegaserod) was reintroduced to the United States market. Therefore, the text has been amended to reflect that ZELNORM (tegaserod) is indeed currently prescribed in the USA. The authors and Cureus sincerely regret the error.